Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer

IMPORTANCE: Stereotactic body radiotherapy harnesses improvements in technology to allow the completion of a course of external beam radiotherapy treatment for prostate cancer in the span of 4 to 5 treatment sessions. Although mounting short-term data support this approach, long-term outcomes have b...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:JAMA Netw Open
المؤلفون الرئيسيون: Kishan, Amar U., Dang, Audrey, Katz, Alan J., Mantz, Constantine A., Collins, Sean P., Aghdam, Nima, Chu, Fang-I, Kaplan, Irving D., Appelbaum, Limor, Fuller, Donald B., Meier, Robert M., Loblaw, D. Andrew, Cheung, Patrick, Pham, Huong T., Shaverdian, Narek, Jiang, Naomi, Yuan, Ye, Bagshaw, Hilary, Prionas, Nicolas, Buyyounouski, Mark K., Spratt, Daniel E., Linson, Patrick W., Hong, Robert L., Nickols, Nicholas G., Steinberg, Michael L., Kupelian, Patrick A., King, Christopher R.
التنسيق: Artigo
اللغة:Inglês
منشور في: American Medical Association 2019
الموضوعات:
Original Investigation
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6484596/
https://ncbi.nlm.nih.gov/pubmed/30735235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2018.8006
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة